The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial

被引:44
|
作者
Hermans, Job [1 ]
Bierma-Zeinstra, Sita M. A. [1 ,2 ]
Bos, Pieter K. [1 ]
Niesten, Dieu Donne [3 ]
Verhaar, Jan A. N. [1 ]
Reijman, Max [1 ]
机构
[1] Erasmus Univ, Dept Orthopaed Surg, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Dept Gen Practice, Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands
[3] Reinier de Graaf Hosp, Dept Orthopaed Surg, POB 5011, NL-2600 GA Delft, Netherlands
关键词
Knee osteoarthritis; Hyaluronic acid; Effectiveness; Randomised controlled trial; Working age; TASK-FORCE; MANAGEMENT; EFFICACY; SOCIETY; BURDEN; COSTS; RISK; HIP;
D O I
10.1186/s12891-019-2546-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundHigh molecular weight (HMW) hyaluronic acid (HA) is a treatment option for knee osteoarthritis (OA). The efficacy of HMW-HA in knee OA is investigated extensively, but the effectiveness in patients in the working age is unknown. Nevertheless, the number knee OA patients in the working age is increasing. Surgical treatment options are less eligible in these patients and productivity losses are high. In this study the effectiveness of intra-articular HMW-HA added to regular non-surgical usual care in everyday clinical practice (UC) compared to UC over 52weeks in symptomatic knee OA patients in the working age was investigated.MethodsIn this open labelled randomized controlled trial, subjects aged between 18 and 65years with symptomatic knee OA (Kellgren and Lawrence I-III) were enrolled and randomized to UC+3 weekly injections with HMW-HA (intervention) or UC only (control). The primary outcome was the between group difference in responders to therapy according to OMERACT-OARSI criteria after 52weeks. These criteria include the domains pain, knee related function and patient's global assessment (PGA). Function was evaluated with the KOOS questionnaire. Pain was assessed with the Numeric Rating Scale. Secondary outcome comprised the between group difference on the individual responder domains, as analysed with a random effects model. Odds Ratios (OR) were calculated by logistic regression analysis. Sensitivity analyses were performed.ResultsIn total, 156 subjects were included (intervention group 77, control group 79). Subjects in the intervention group (HMW-HA+UC) were more often responder compared to the controls (UC). Depending on whether pain during rest or pain during activity was included in the responder domains, 57.1% versus 34.2% (p=0.006) and 54.5% versus 34.2% (p=0.015) was responder to therapy respectively. The results of the secondary outcome analyses show that scores on individual responder domains over all follow-up moments were statistically significant in favour of the intervention group in the domains pain during rest ( 0.8, 95%CI 0.2; 1.4, p=0.010), knee related function ( -6.8, 95%CI -11.9; -1.7, p=0.010) and PGA ( -0.7, 95%CI -0.9; -0.4, p<0.0001).ConclusionsIntra-articular HMW-HA added to usual care is effective for knee OA in patients in the working age.Trial registrationwww.trialregister.nl, NTR1651, registered 2009-3-3.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Similar Efficacy of Different Molecular Weight Hyaluronic Acid Preparations in the Treatment of Osteoarthritis of the Knee
    Ozgonenel, Levent
    Aytekin, Ebru
    Kavadar, Gulis
    Ornek, Gul Tugba
    Gunaydin, Safak
    Suyabatmaz, Ozgur
    Saylik, Derya
    Tolga, Seyma
    ISTANBUL MEDICAL JOURNAL, 2008, 9 (02): : 53 - 57
  • [22] Randomised controlled trial (RCT) showing knee osteoarthritis (OA) responds to a single intra-articular hyaluronic acid injection
    Scott, David L.
    Chevalier, Xavier
    Luyten, Frank P.
    Jerosch, Joerg
    van Dijk, C. N.
    Bailleul, Francois
    Pavelka, Karel
    RHEUMATOLOGY, 2008, 47 : II178 - II179
  • [23] Oral hyaluronic acid in patients with knee osteoarthritis
    Andor, Bogdan Corneliu
    Cerbu, Simona
    PROGRESS IN NUTRITION, 2019, 21 (01): : 243 - 245
  • [24] Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: a randomised controlled trial in primary care
    Verkleij, Saskia P. J.
    Luijsterburg, Pim A. J.
    Willemsen, Sten P.
    Koes, Bart W.
    Bohnen, Arthur M.
    Bierma-Zeinstra, Sita M. A.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2015, 65 (637): : E530 - E537
  • [25] Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial
    O'Reilly, SC
    Muir, KR
    Doherty, M
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (01) : 15 - 19
  • [26] Evaluation of single and multiple hyaluronic acid injections at different concentrations with high molecular weight in the treatment of knee osteoarthritis
    Selim Safali
    Erkan Sabri Ertaş
    Ali Özdemir
    Deniz Cataklı
    BMC Musculoskeletal Disorders, 25
  • [27] Long term efficacy and safety of a combined low and high molecular weight hyaluronic acid in the treatment of osteoarthritis of the knee
    Petrella, Robert J.
    Decaria, Joseph
    Petrella, Michael J.
    RHEUMATOLOGY REPORTS, 2011, 3 (01) : 16 - 21
  • [28] Evaluation of single and multiple hyaluronic acid injections at different concentrations with high molecular weight in the treatment of knee osteoarthritis
    Safali, Selim
    Ertas, Erkan Sabri
    Ozdemir, Ali
    Catakli, Deniz
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [29] Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial
    Migliore, Alberto
    Blicharski, Tomasz
    Plebanski, Rafal
    Zegota, Zbigniew
    Gyula, Gyorfi
    Rannou, Francois
    Reginster, Jean-Yves
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1617 - 1636
  • [30] Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial
    Alberto Migliore
    Tomasz Blicharski
    Rafal Plebanski
    Zbigniew Zegota
    Győrfi Gyula
    François Rannou
    Jean-Yves Reginster
    Rheumatology and Therapy, 2021, 8 : 1617 - 1636